glp-1 injections side effects Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds Ozempic, Mounjaro: 6 'Hidden' Side

The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight

Whether GLP-1 analogs reduce cardiovascular events will be determined by important clinical trials currently underway (e.g., EXSCEL for exenatide and LEADER for liraglutide) [33]

To view or add a comment, sign in With the Wegovy pill and Foundayo now available in the U.S., plan sponsors need to ensure their benefits strategy is ready to adapt to increased demand and future GLP-1 developments

Ive been following the data on these new drugs with fascination and cautious optimism about their potential for both individual and population health

Side effects are rare and mild